Oral News and Research

RSS

$Young athletes undergoing intense training have higher risk of stress fractures, other overuse injuries$

Young athletes undergoing intense training have higher risk of stress fractures, other overuse injuries

Young athletes who specialize in one sport and train intensively have a significantly higher risk of stress fractures and other severe overuse injuries, even when compared with other injured athletes, according to the largest clinical study of its kind.

22 Apr 2013

IMRT reduces feelings of dry mouth in patients with head and neck cancers

Geneva, Switzerland: Researchers have shown for the first time that it is possible to reduce the distressing symptoms of dry mouth in patients treated with radiotherapy for head and neck cancers if the radiation dose to a salivary gland (called the submandibular gland) on the opposite side to the tumour is kept to the minimum.

22 Apr 2013

Edible malarial vaccine may work against other viral and bacterial infections

Can scientists rid malaria from the Third World by simply feeding algae genetically engineered with a vaccine? That's the question biologists at UC San Diego sought to answer after they demonstrated last May that algae can be engineered to produce a vaccine that blocks malaria transmission.

22 Apr 2013

Sleep related breathing disorders associated with cognitive and behavioral impairment in children

People lobbying for gun control may want to consider another culprit in the post-Newtown search for the answer to our unfathomable questions.

22 Apr 2013

Potential therapies for smell loss

Snot. It's not something most of us spend a lot of time thinking about, but, for a team of researchers in Washington, D.C., it's front and center.

22 Apr 2013

Civitas Therapeutics reports positive results from Phase 2 study of CVT-301 for Parkinson's disease

Civitas Therapeutics, Inc., a privately-held pharmaceutical company developing transformative therapeutics using the ARCUS respiratory delivery platform, today announced positive topline results from a Phase 2 clinical trial of CVT-301, an inhaled formulation of levodopa (L-dopa).

20 Apr 2013

Romark Laboratories starts NT-300 Phase 3 trial for treatment of acute uncomplicated influenza

Romark Laboratories announced that it has begun enrolling patients in a global Phase 3 clinical trial of NT-300 (nitazoxanide) for treatment of acute uncomplicated influenza.

19 Apr 2013

ARMGO Pharma gets $1 million to support ARM210 preclinical work for DMD treatment

ARMGO Pharma and the Muscular Dystrophy Association today announced that $1 Million has been awarded for preclinical work in support of an Investigational New Drug application with the U.S. Food and Drug Administration for ARM210, a novel, orally available, small-molecule Rycal drug that has potential as a treatment for Duchenne muscular dystrophy.

18 Apr 2013

European Congress on Osteoporosis & Osteoarthritis starts in Rome

The world's largest congress dedicated to the epidemiology, pathogenesis, prevention, and treatment of osteoporosis and osteoarthritis has opened today in Rome, Italy with 4500 delegates.

18 Apr 2013

Phase IIa study shows safety and efficacy of BL-7040 in treating ulcerative colitis

BioLineRx, a biopharmaceutical development company, announced today positive Phase IIa results for BL-7040, an orally available drug for treating inflammatory bowel disease.

17 Apr 2013

Updated labeling for Purdue Pharma's reformulated OxyContin tablets gets FDA approval

The U.S. Food and Drug Administration today approved updated labeling for Purdue Pharma L.P.'s reformulated OxyContin (oxycodone hydrochloride controlled-release) tablets.

17 Apr 2013

High court seems skeptical that biotech firm can patent human genes

Supreme Court justices seemed to express skepticism Monday that a biotech company can patent human genes isolated from the body that signal a greater likelihood of ovarian or breast cancer.

17 Apr 2013

First Edition: April 16, 2013

Today's headlines include coverage of the Supreme Court oral arguments regarding whether patents should be granted for human genes.

16 Apr 2013

Roundup: Ariz. gov. vetoes bill that would require docs to post prices online, long-term care costs soar in Virginia

Gov. Jan Brewer vetoed legislation Friday that would have required doctors, hospitals and other health care providers to post prices for their most common services, a move the bill's sponsor said was a blow to consumers and driven by industry pressure.

16 Apr 2013

GTx to continue two pivotal Phase III clinical trials of enobosarm

GTx, Inc. today announced that a per protocol safety review of unblinded safety data on Friday April 12, 2013, by an independent Data Safety Monitoring Board, resulted in a determination that GTx continue as planned its two pivotal Phase III clinical trials of enobosarm (GTx-024) for the prevention and treatment of muscle wasting in patients with advanced non-small cell lung cancer.

16 Apr 2013

NeuroDerm enrolls patients for Phase IIa clinical trial of ND0612

NeuroDerm, Ltd. announced today that enrollment of patients is ongoing in its Phase IIa clinical trial of ND0612, a novel drug formulation for the treatment of Parkinson's disease.

16 Apr 2013

Study shows mathematical models can help assess effectiveness of HIV intervention combinations

South Africa is home to the largest HIV epidemic in the world with a total of 5.6 million people living with HIV. Large-scale clinical trials evaluating combination methods of prevention and treatment are often prohibitively expensive and take years to complete.

16 Apr 2013

KYTHERA Biopharmaceuticals reports positive results from Phase IIb study of ATX-101

KYTHERA Biopharmaceuticals, Inc. today presented positive results that found MRI measurements of patients treated with ATX-101 demonstrated a statistically significant reduction in submental fat, commonly known as double chin, during an oral session at The Aesthetic Meeting 2013, organized by the American Society for Aesthetic Plastic Surgery, April 11-16, New York, NY.

15 Apr 2013

WHO, UNICEF launch new Global Action Plan to save children from pneumonia and diarrhoea

A new Global Action Plan launched today by the WHO and UNICEF has the potential to save up to 2 million children every year from deaths caused by pneumonia and diarrhoea, some of the leading killers of children under five globally.

15 Apr 2013

State highlights: Baby boomers eye expanding end-of-life rights in states across nation; Calif. judges threaten governor with contempt of court over prison care

Claudia Burzichelli doesn't want to die like her dad. … In states across the country, including New Jersey, Connecticut, Massachusetts and Vermont, graying baby boomers have been lobbying lawmakers in recent months at hearings, in letters and by phone, pushing to make it legal for doctors to prescribe life-ending drugs to terminally ill patients.

15 Apr 2013

Oral News and Research

Young athletes undergoing intense training have higher risk of stress fractures, other overuse injuries

IMRT reduces feelings of dry mouth in patients with head and neck cancers

Edible malarial vaccine may work against other viral and bacterial infections

Sleep related breathing disorders associated with cognitive and behavioral impairment in children

Potential therapies for smell loss

Civitas Therapeutics reports positive results from Phase 2 study of CVT-301 for Parkinson's disease

Romark Laboratories starts NT-300 Phase 3 trial for treatment of acute uncomplicated influenza

ARMGO Pharma gets $1 million to support ARM210 preclinical work for DMD treatment

European Congress on Osteoporosis & Osteoarthritis starts in Rome

Phase IIa study shows safety and efficacy of BL-7040 in treating ulcerative colitis

Updated labeling for Purdue Pharma's reformulated OxyContin tablets gets FDA approval

High court seems skeptical that biotech firm can patent human genes

First Edition: April 16, 2013

Roundup: Ariz. gov. vetoes bill that would require docs to post prices online, long-term care costs soar in Virginia

GTx to continue two pivotal Phase III clinical trials of enobosarm

NeuroDerm enrolls patients for Phase IIa clinical trial of ND0612

Study shows mathematical models can help assess effectiveness of HIV intervention combinations

KYTHERA Biopharmaceuticals reports positive results from Phase IIb study of ATX-101

WHO, UNICEF launch new Global Action Plan to save children from pneumonia and diarrhoea

State highlights: Baby boomers eye expanding end-of-life rights in states across nation; Calif. judges threaten governor with contempt of court over prison care

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

Latest News